SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-008492
Filing Date
2023-05-22
Accepted
2023-05-22 16:20:12
Documents
1
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 form4-05222023_040501.html 4  
1 form4-05222023_040501.xml 4 3969
  Complete submission text file 0001415889-23-008492.txt   5336
Mailing Address AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Cole Douglas G. (Reporting) CIK: 0001486373 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 23944690

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations